Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

Statistical Methods in Medical Research

Volumn 22, Issue 1, 2013, Pages 57-69

  Norén, G Niklas ^a,b   Hopstadius, Johan ^a   Bate, Andrew ^a,c  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

adverse drug reactions; exploratory analysis; pattern discovery; statistical shrinkage

Indexed keywords

ARTICLE; CONTINGENCY TABLE; CONTRAST; DATA BASE; HUMAN; LARGE SCALE PRODUCTION; LOGLINEAR MODEL; METHODOLOGY; POLICY; REGULATORY MECHANISM; RISK; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRATIFIED SAMPLE;

MODELS, STATISTICAL;

EID: 84862216660     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280211403604     Document Type: Article

References (23)

1. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998 ; 54: 315-321 (Pubitemid 28328016)
2. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999 ; 53: 177-202
3. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards IR. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005 ; 365: 482-487 (Pubitemid 40215730)
4. Edwards IR, Bate A, Lindquist M. Abacavir and increased risk of myocardial infarction. Lancet. 2008 ; 372 (9641). 805-805
5. Hand DJ, Bolton R. Pattern Discovery and Detection: A Unified Statistical Methodology. J Appl Stat. 2004 ; 31 (8). 885-924 (Pubitemid 39518784)
6. DuMouchel W, Pregibon D. Empirical Bayes screening for multi-item associations. KDD '01: Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining ; San Francisco, CA, 2001, pp. 67-76.
7. Norén GN, Bate A, Orre R, Edwards IR. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med. 2006 ; 25 (21). 3740-3757 (Pubitemid 44613906)
8. Norén GN, Sundberg R, Bate A, Edwards IR. A statistical methodology for drug-drug interaction surveillance. Stat Med. 2008 ; 27 (16). 3057-3070
9. Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Mining Knowledge Discov. 2010 ; 20 (3). 361-387
10. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemio. Drug Saf. 2001 ; 10 (6). 483-486 (Pubitemid 34100774)
11. Tan P, Kumar V, Srivastava J. Selecting the right interestingness measure for association patterns. KDD '02: Proceedings of the Eighth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining ; ACM, New York, NY, USA, 2002, pp. 32-41.
12. Lindquist M. VigiBase, the WHO global ICSR database system: basic facts. Drug Inf J. 2008 ; 42: 409-419
13. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980 ; 112 (4). 467-470 (Pubitemid 10029548)
14. Hopstadius J, Norén GN, Bate A, Edwards IR. Adjustment for potential confounders in adverse drug reaction surveillance. Drug Saf. 2008 ; 31 (11). 1035-1048
15. James W, Stein J Estimation with quadratic loss. In: Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability. Neyman J, ed. Berkeley, CA: University of California Press ; 1961: 361-379.
16. Gould AL. Accounting for multiplicity in the evaluation of 'signals' obtained by data mining from spontaneous report adverse event databases. Biometric J. 2007 ; 49 (1). 151-165
17. Webb GI. Discovering significant patterns. Mach Learn. 2007 ; 68 (1). 1-33 (Pubitemid 46828725)
18. Ahmed I, Thiessard F, Miremont-Salamé G, Bégaud B, Tubert-Bitter P. Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study. Clin Pharmacol Ther. 2010 ; 88 (4). 492-498
19. Cox DR. Statistical significance tests. Br J Clin Pharmacol. 1982 ; 14 (3). 325-331 (Pubitemid 13139128)
20. Norén GN, Orre R, Bate A, Edwards IR. Duplicate detection in adverse drug reaction surveillance. Data Mining Knowledge Discov. 2007 ; 14: 305-328 (Pubitemid 46582604)
21. Hauben M, Madigan D, Hochberg AM, Reisinger SJ, O'Hara DJ. Data mining in pharmacovigilance: computational cost as a neglected performance parameter. Int J Pharm Med. 2007 ; 21 (5). 319-323 (Pubitemid 47416281)
22. Genkin A, Lewis DD, Madigan D. Large-scale Bayesian logistic regression for text categorization. Technometrics. 2007 ; 49 (3). 291-304 (Pubitemid 47292487)
23. Caster O, Norén GN, Madigan D, Bate A. Large-scale regression-based pattern discovery: the example of screening the WHO global drug safety database. Stat Anal Data Mining. 2010 ; 3 (4). 197-208